Dia.Pro Diagnostic Bioprobes

Dia.Pro Diagnostic Bioprobes is an Italian in vitro diagnostics company focused on infectious disease and selected autoimmune testing. The company develops, manufactures, and markets CE-marked diagnostic reagents, assay kits, and automated systems, with product lines spanning ELISA, chemiluminescence immunoassays, RT-PCR, rapid tests, and confirmatory assays. Its menu covers major blood-borne and emerging infectious diseases including HIV, viral hepatitis, syphilis, malaria, dengue, Zika, chikungunya, and SARS-CoV-2. Dia.Pro has historically operated as a vertically integrated manufacturer with internal production from biological raw materials through finished IVD assays and global distribution across more than 100 countries. In December 2025, the company was acquired by Clonit, positioning it within a broader Italian diagnostics group.